Evidence from human cohorts indicates that chronic insomnia is associated with higher risk
of cardiometabolic diseases (CMD), yet whether gut microbiota plays a role is unclear. Here, …

The COVID-19 pandemic is spreading globally with high disparity in the susceptibility of the
disease severity. Identification of the key underlying factors for this disparity is highly …

Background Identifying new drug targets for inflammatory bowel disease (IBD) is urgently
needed. The proteome is a major source of therapeutic targets. We conducted a proteome-…

OBJECTIVE To identify the core gut microbial features associated with type 2 diabetes risk
and potential demographic, adiposity, and dietary factors associated with these features. …

Background Little is known about the inter-relationship among fruit and vegetable intake, gut
microbiota and metabolites, and type 2 diabetes (T2D) in human prospective cohort study. …

Background Interest in the interplay between host genetics and the gut microbiome in
complex human diseases is increasing, with prior evidence mainly being derived from animal …

Blood metabolome is commonly used in human studies to explore the associations of gut
microbiota-derived metabolites with cardiometabolic diseases. Here, in a cohort of 1007 middle…

Background To explore the associations of genetically proxied TYK2 inhibition with a wide
range of disease outcomes and biomarkers to identify therapeutic repurposing opportunities, …

Background Circulating vitamin C concentrations have been associated with several cancers
in observational studies, but little is known about the causal direction of the associations. …

Gut microbial dysbiosis has been linked to many noncommunicable diseases. However,
little is known about specific gut microbiota composition and its correlated metabolites …